Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

LIXISENATIDE

FDA · BLA · 2026-03-12

AgencyFDA
Submission typeBLA
Action date2026-03-12
BrandADLYXIN
SponsorSANOFI-AVENTIS US
RouteSUBCUTANEOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:43.350Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:LIXISENATIDE:2026-03-12

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

LIXISENATIDE — approval | AEaH